As RSG® Arrive continues to transform the clinical trial patient experience – enhancing access to care, removing barriers to participation, and fostering long-term engagement – we recognize Mike as our driver of the month. He exemplifies the qualities that set RSG® Arrive apart – dedication, commitment to care, and professionalism.
As one of the most requested RSG® Arrive drivers in Chicago, Mike has completed over 100 trips in the last 18 months alone, driving patients to and from their study visits. The most satisfying part of his job comes from helping others in need. Whether it’s with the kind offer of “Let me help you out with that” or “Let me hold that bag for you,” Mike is always looking to help others. “That’s basically how we should all be," Mike says. "If you see someone who is suffering and they need something, offer them a hand – it doesn’t cost anything. It’s just a good gesture and a good deed of the day that everybody should be doing.”
A professional driver in Chicago for over 13 years, Mike enjoys connecting with new people every day. He likes that there’s nothing routine about his day. “Every day could be something new and different. It’s always nice knowing that tomorrow you don’t know what is going to happen, but you’re curious how it will turn out.”
Mike enjoys the energy of the city. “Chicago is a big melting pot of all types of people.” And he enjoys the wide range of restaurants. With three young children, he keeps busy in his free time, often enjoying family gatherings and picnics.
About RSG® Arrive
RSG® Arrive enhances access to care, removes barriers to participation, and fosters long-term engagement. Developed specifically for clinical research, RSG® Arrive is a concierge service that manages all patient travel – from simple ground transportation to complex international travel. At its core, RSG® Arrive features a commitment to care that transforms the patient experience while accelerating enrollment success.
To learn more about RSG® Arrive and how it meets the needs of today’s clinical trial participants, click here.